RARE
ULTRAGENYX PHARM
Health Care·Biotechnology·UNITED STATES
$15.30
MCap —
as of 2026-09-04
Total
E1w
Fund
D9w
Quant
E1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
-0.93
Sentiment 88.9%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$15.30
Adaptive Mean
$18.58
-3.28 vs mean
Adaptive σ
1.77
MIDOS BB
$15.04 – $22.13
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-06
Composite Z
-0.76
ROE
—
Z -3.23
Rev Gr
-2.2%
Z -0.32
EPS Gr
—
Z -0.05
OPM Gr
-21.4%
Z -0.50
FCF Yld
-8.7%
Z -1.06
EPS Surp
-0.1%
Z -0.28
EPS 3mo Δ
14.8%
Z +0.12
Fwd P/E
38.04
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
-4.61
Q6M
-4.20
Q12M
-3.97
MA 30/100
0.961
Bearish (MA30 < MA100)
α (Jensen)
-0.7724
β (12M)
1.21
σ (12M)
0.804
Divergence — Fundamentals vs Momentum
Z Percentile
5%
Q Percentile
19%
Divergence
-13.9
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
-43.9
RS Pctl
7%
RS Decile
D1
Persistence
1w
at grade E
Options / OI Analysis
No options or Williams data available for this ticker.